Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment SK Malladi, R Singh, S Pandey, S Gayathri, K Kanjo, S Ahmed, MS Khan, ... Journal of Biological Chemistry 296, 2021 | 48 | 2021 |
SARS-CoV-2 cellular entry is independent of the ACE2 cytoplasmic domain signaling T Karthika, J Joseph, VRA Das, N Nair, P Charulekha, MD Roji, VS Raj Cells 10 (7), 1814, 2021 | 39 | 2021 |
Green tea and Spirulina extracts inhibit SARS, MERS, and SARS-2 spike pseudotyped virus entry in vitro J Joseph, A Ajay, VRA Das, VS Raj BioRxiv, 2020.06. 20.162701, 2020 | 19 | 2020 |
The use of pseudotyped coronaviruses for the screening of entry inhibitors: Green tea extract inhibits the entry of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 by blocking receptor … J Joseph, T Karthika, VRA Das, VS Raj Current pharmaceutical biotechnology, 2021 | 11 | 2021 |
Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis A Datey, M Shreenivas, G Chandrasekharan, J Joseph, S Sah, S Aluri, ... Vaccine 36 (50), 7715-7727, 2018 | 6 | 2018 |
Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses J Joseph, T Karthika, VRA Das, VS Raj Journal of Global Antimicrobial Resistance 26, 26, 2021 | 2 | 2021 |
SARS‐CoV‐2 neutralizing antibody epitopes are overlapping and highly mutated which raises the chances of escape variants and requires development of broadly reactive vaccines J Joseph, S Darpe, G Kulkarni, VS Raj Proteins: Structure, Function, and Bioinformatics 91 (8), 1021-1031, 2023 | | 2023 |
SARS-CoV-2 neutralizing antibody epitopes are overlapping and highly mutated which raises the chances of escape variants and requires development of broadly reactive vaccines VS Raj, J Joseph, S Darpe, G Kulkarni Authorea Preprints, 2022 | | 2022 |
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment immunogen bioRxiv, 2020 | | 2020 |
The study of highly pathogenic emerging RNA viruses using recombinant envelope proteins and pseudotyped viruses J Joseph Thiruvananthapuram, 0 | | |